XBiotech (XBIT) Change in Accrued Expenses (2014 - 2026)
XBiotech (XBIT) reported Change in Accrued Expenses of $3.9 million for Q4 2025, compared with -$1.86 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Change in Accrued Expenses (2014 - 2026) Analysis & Trends
For FY2025, XBiotech posted Change in Accrued Expenses of $3.69 million.
- By year, Change in Accrued Expenses came in at -$877,000 in FY2024, $1.9 million in FY2023 (+727.5%), $229,000 in FY2022 (+895.7%) and $23,000 in FY2021.
- The Q4 2025 figure ranks as the highest quarterly Change in Accrued Expenses since Q2 2022.
- Per Business Quant data, the three quarters before Q4 2025 came in at $12,000 (Q3 2025), -$1.89 million (Q2 2025) and $1.67 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | XBiotech | 58.23 Mn | -439.75 Mn | - | 212,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 212,000.00 |
| Mar 31, 2026 | -4.28 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | -1.89 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Sep 30, 2024 | -861,000.00 |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | -168,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 429,000.00 |
| Mar 31, 2023 | 602,000.00 |
| Dec 31, 2022 | -385,000.00 |
| Sep 30, 2022 | -3.60 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | -269,000.00 |
| Sep 30, 2021 | -38,000.00 |
API Access
XBiotech Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();